- Home
- PPBT vs XPON Comparison
PPBT vs XPON Comparison
Compare PPBT & XPON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- XPON
- Stock Information
- Founded
- PPBT 2010
- XPON 2016
- Country
- PPBT Israel
- XPON United States
- Employees
- PPBT N/A
- XPON N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- XPON Electronic Components
- Sector
- PPBT Health Care
- XPON Technology
- Exchange
- PPBT Nasdaq
- XPON Nasdaq
- Market Cap
- PPBT 5.5M
- XPON 6.2M
- IPO Year
- PPBT N/A
- XPON 2022
- Fundamental
- Price
- PPBT $0.58
- XPON $1.52
- Analyst Decision
- PPBT Strong Buy
- XPON
- Analyst Count
- PPBT 1
- XPON 0
- Target Price
- PPBT $33.00
- XPON N/A
- AVG Volume (30 Days)
- PPBT 408.1K
- XPON 3.0M
- Earning Date
- PPBT 11-14-2025
- XPON 11-13-2025
- Dividend Yield
- PPBT N/A
- XPON N/A
- EPS Growth
- PPBT N/A
- XPON N/A
- EPS
- PPBT N/A
- XPON N/A
- Revenue
- PPBT N/A
- XPON $8,414,250.00
- Revenue This Year
- PPBT N/A
- XPON $61.26
- Revenue Next Year
- PPBT N/A
- XPON N/A
- P/E Ratio
- PPBT N/A
- XPON N/A
- Revenue Growth
- PPBT N/A
- XPON 68.33
- 52 Week Low
- PPBT $0.53
- XPON $0.60
- 52 Week High
- PPBT $13.95
- XPON $5.50
- Technical
- Relative Strength Index (RSI)
- PPBT 19.96
- XPON 51.30
- Support Level
- PPBT $0.57
- XPON $1.36
- Resistance Level
- PPBT $0.62
- XPON $1.80
- Average True Range (ATR)
- PPBT 0.03
- XPON 0.17
- MACD
- PPBT 0.06
- XPON 0.01
- Stochastic Oscillator
- PPBT 45.09
- XPON 32.93
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.